Lexeo Therapeutics (LXEO) Stock Forecast & Price Target

$10.90

-0.50 (-4.39%)

(As of 09/6/2024 ET)

Lexeo Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 9 Analyst Ratings

Based on 9 Wall Street analysts who have issued ratings for Lexeo Therapeutics in the last 12 months, the stock has a consensus rating of "Buy." Out of the 9 analysts, 8 have given a buy rating, and 1 has given a strong buy rating for LXEO.

Consensus Price Target

$22.14
103.15% Upside

High Forecast	$28.00
Average Forecast	$22.14
Low Forecast	$19.00

According to the 9 analysts' twelve-month price targets for Lexeo Therapeutics, the average price target is $22.14. The highest price target for LXEO is $28.00, while the lowest price target for LXEO is $19.00. The average price target represents a forecasted upside of 103.15% from the current price of $10.90.

Type	Current Forecast 9/8/23 to 9/7/24	1 Month Ago 8/9/23 to 8/8/24	3 Months Ago 6/10/23 to 6/9/24	1 Year Ago 9/8/22 to 9/8/23
Consensus Rating	Buy	Buy	Buy	N/A
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	8 Buy rating(s)	8 Buy rating(s)	7 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$22.14	$22.00	$21.00	N/A
Forecasted Upside	103.15% Upside	74.58% Upside	74.54% Upside	N/A

Get Lexeo Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for LXEO and its competitors with MarketBeat's FREE daily newsletter.

Ad Golden Crest

Biden’s Capital Gains Tax to Devastate Savings!

Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.

>> Get Your FREE Wealth Protection Guide <<

LXEO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

LXEO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Lexeo Therapeutics Stock vs. The Competition

Type	Lexeo Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	3.11	2.77	2.51
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	103.15% Upside	1,206.56% Upside	11.36% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/14/2024	Chardan Capital 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$23.00 ➝ $23.00	+96.58%
8/13/2024	HC Wainwright 2 of 5 stars	M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$22.00 ➝ $21.00	+84.86%
8/13/2024	Royal Bank of Canada 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$24.00 ➝ $24.00	+111.45%
6/13/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Skorney Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/13/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$28.00	+53.93%
11/28/2023	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Foroohar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
11/28/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$20.00	+81.82%
11/28/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$20.00	+81.82%
11/28/2023	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$19.00	+72.73%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:48 PM ET.

LXEO Forecast - Frequently Asked Questions

What is Lexeo Therapeutics' forecast for 2024?: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Lexeo Therapeutics is $22.14, with a high forecast of $28.00 and a low forecast of $19.00.
Should I buy or sell Lexeo Therapeutics stock right now?: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lexeo Therapeutics in the last year. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LXEO shares.
Does Lexeo Therapeutics's stock price have much upside?: According to analysts, Lexeo Therapeutics's stock has a predicted upside of 81.07% based on their 12-month stock forecasts.
Has Lexeo Therapeutics been upgraded by Wall Street analysts recently?: Over the previous 90 days, Lexeo Therapeutics's stock had 1 upgrade by analysts.
What analysts cover Lexeo Therapeutics?: Lexeo Therapeutics has been rated by research analysts at Baird R W, Chardan Capital, HC Wainwright, Robert W. Baird, and Royal Bank of Canada in the past 90 days.
Do Wall Street analysts like Lexeo Therapeutics more than its competitors?: Analysts like Lexeo Therapeutics more than other "medical" companies. The consensus rating for Lexeo Therapeutics is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how LXEO compares to other companies.